Nosological Tunnel Vision in Biological Psychiatry
A Plea for a Functional Psychopathology
H. M. VAN PRAAG
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorG. M. ASNIS
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorR. S. KAHN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorS. L. BROWN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorM. KORN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorJ. M. HARKAVY FRIEDMAN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorS. WETZLER
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorH. M. VAN PRAAG
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorG. M. ASNIS
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorR. S. KAHN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorS. L. BROWN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorM. KORN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorJ. M. HARKAVY FRIEDMAN
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this authorS. WETZLER
Department of Psychiatry Albert Einstein College of Medicine/Montefiore Medical Center Bronx, New York 10467
Search for more papers by this author
References
- 1 Van Praag, H. M. & B. Leijnse 1965. Neubewertung des syndroms. Skizze einer funktionellen Pathologie. Psychiatr. Neurol. Neurochir. 68: 50–66.
- 2 van Praag, H. M. J. Korf, J. P. W. F. Lakke & T. Schut 1975. Dopamine metabolism in depression, psychoses, and parkinson's diesase: The problem of the specificity of biological variables in behaviour disorders. Psychol. Med. 5: 138–146.
- 3 Van Praag, H. M., R. Kahn, G. M. Asnis, S. Wetzler, S. Brown, A. Bleich & M. Korn 1987a. Denosologization of biological psychiatry on the specificity of 5-HT disturbances in psychiatric disorders. J. Affect. Dis. 13: 1–8.
- 4 van Praag, H. M., G. M. Asnis, S. L. Brown, M. Korn, J. M. Harkavy Friedman & S. Wetzler 1990. Beyond serotonin. A multi-aminergic perspective on abnormal behavior. In Serotonin in Psychiatric Disorders. S. L. Brown and H. M. Praag, Eds. New York : Brunner/Mazel. In press.
- 5 Van Praag, H. M., J. Korf & J. Puite 1970. 5-hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225: 1259–1260.
- 6 Brown, S. L., A. Bleich & H. M. Van Praag 1990. The monoamine hypothesis of depression: The case for serotonin. In The Role of Serotonin in the Psychiatric Disorders. S. L. Brown & H. M. Praag, Eds. New York : Brunner/Mazel. In press.
- 7 Van Praag, H. M. 1982. Neurotransmitters and CNS disease: Depression. Lancet II: 1259–1264.
- 8 Goodwin, F. V. & R. M. Post 1983. 5 hydroxytryptamine and depression: A model for the interaction of normal variances and pathology. Br. J. Clin. Pharmacol. 15: 393–3405.
- 9 Van Praag, H. M. & J. Korf 1971. Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification? Psychopharmacology 19: 148–152.
- 10 Van Praag, H. M. & C. Lemus 1986. Monoamine precursors in the treatment of psychiatric disorders. In Nutrition and the Brain. R. J. Wurtman and J. J. Wurtman, Eds. New York : Raven Press, pp. 89–138.
- 11 Van Praag, H. M. 1984. In search of the mode of action of antidepressants: 5-HT-tryosine mixtures in depressions. Neuropharamacology 22: 433–440.
- 12 Van Praag, H. M., C. Lemus & R. Kahn 1987b. Hormonal probes of central serotonergic activity. Do they really exist? Bio. Psych. 22: 86–98.
- 13 Van Praag, H. M. 1986a. Serotonin precursors with and without tyrosine in the treatment of depression.In Biological Psychiatry. C. Shagrass, R. Josias, W. Bridger, K. Weiss & D. Stoff and J. Simpson, Eds. New York : Elsevier Science Publishers Inc.
- 14 Raleigh, M. J. 1987. Differential behavioral effects of tryptophan and 5-hydroxytryptophan in vervet monkeys: Influence of catecholaminergic systems. Psychopharmacology 93: 44–50.
- 15 Asberg, M., L. Traksman & P. Thoren 1976. 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch. Gen. Psych. 33: 1193–1197.
- 16 Van Praag, H. M. 1986b. Biological suicide research. Outcome and limitations. Biol. Psych. 21: 1305–1323.
- 17 Brown, G. L., F. K. Goodwin, J. C. Ballenger, P. F. Goyer & L. F. Major 1979. Aggression in humans correlates with cerebrospinal fluid metabolites. Psych. Res. 1: 131–139.
- 18 Brown, G. L., M. E. Ebert, P. F. Goyer, D. C. Jimerson, W. J. Klein, W. E. Bunney & F. K. Goodwin 1982. Aggression, suicide and serotonin: Relationships to CSF amine metabolites. Am. J. Psych. 139: 741–746.
- 19 Bioulac, B., M. Benezich, B. Renaud, B. Noel & D. Roche 1980. Serotonergic functions in the 47, XYZ syndrome. Biol. Psych. 15: 917–23.
- 20 Linnoila, M., M. Virkhunen, M. Scheinin, A. Nuutila, R. Rimon & F. K. Goodwin 1983. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 33: 2609–2614.
- 21 Lidberg, L., M. Asberg & U. B. Sundquist-Stensman 1984. 5-Hydroxyindoleacetic acid in attempted suicides who have killed their children. Lancet II: 928.
- 22 Lidberg, L., J. R. Tuck, M. Asberg, G. P. Scalia-Tomba & L. Bertilsson 1985. Homicide, suicide and CSF 5-HIAA. Acta Psychiatr. Scand. 71: 230–236.
- 23 Virkkunen, M., A. Nuutila, F. K. Goodwin & M. Linnoila 1987. Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch. Gen. Psych. 44: 241–247.
- 24 Plutchik, R., H. M. Van Praag & H. R. Conte 1989. Correlates of suicide and violence risk, III. A 2-stage model of countervailing forces. Psych. Res. 28: 215–225.
- 25 Van Praag, H. M., R. Plutchik & H. Conte 1986. The serotonin-hypothesis of (auto) aggression. Critical appraisal of the evidence. Ann. N.Y. Acad. Sci. 487: 150–167.
- 26 Evans, L. & G. Moore 1981. The treatment of phobic anxiety by zimeldine. Acta Psychiatr. Scand. 63(290): 342–345.
- 27 Koczkas, S., G. Holmberg & L. Wedin 1981. A pilot study of the effect of the 5-HT uptake inhibitor, zimelidine, on phobic anxiety. Acta Psychiatr. Scand. 63(290): 328–341.
- 28 Evans, L., J. Kenardy, P. Schneider & H. Hoey 1986. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. Acta Psychiatr. Scand. 73: 49–53.
- 29 Kahn, R. S., H. G. M. Westenberg & J. Jolles 1984. Zimelidine treatment of obsessive-compulsive disorder. Acta Psychiatr. Scand. 69: 259–61.
- 30 Kahn, R. S., H. G. M. Westenberg, W. M. A. Verhoeven, C. C. Gispen-de Wied & W. D. J. Kamerbeek 1987. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders: A double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. Inter. Clin. Psychopharmacol. 2: 33–45.
- 31 Den Boer, J. A., H. G. M. Westenberg, W. D. J. Kamerbeek, W. M. A. Verhoeven & R. S. Kahn 1987. Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Inter. Clin. Psychopharm. 2: 21–32.
- 32 Kahn, R. S. & H. G. M. Westenberg 1985. l-5-Hydroxytryptophan in the treatment of anxiety disorders. J. Affect. Dis. 8: 197–200.
- 33 Kahn, R. S., H. M. van Praag. S. Wetzler, G. M. Asnis & G. Barr 1988. Serotonin and anxiety revisited. Biol. Psych. 23: 189–208.
- 34 Kahn, R. S., S. Wetzler, H. M. Van Praag & G. M. Asnis 1988. Behavioral indications for receptor hypersensitivity in panic disorder. Psych. Res. 25: 101–104.
- 35 Kahn, R. S., S. Wetzler, H. M. Van Praag & G. M. Asnis 1988. Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder. Psychopharmacology 96: 360–364.
- 36 Taylor, D. P., M. S. Eison, L. A. Riblet & C. P. Vandermaelen 1985. Pharmacological and clinical effects of buspirone. Pharmacol. Biochem. Behav. 23: 687–694.
- 37 Ceulemans, D. L. S., M. I. J. A. Hoppenbrouwers, Y. Gelders & A. J. M. Reyntjens 1985. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: A double-blind placebo-controlled study versus lorazepam. Pharmakopsychiatria 18: 303–305.
- 38 Jones, B. J., B. Costall, A. M. Domeney, M. E. Kelly, R. J. Naylor, N. R. Oakley & M. B. Tyers 1988. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist. Br. J. Pharmacol. 93: 985–993.
- 39 Banki, C. M. 1977. Correlation between CSF metabolites and psychomotor activity in affective disorders. J. Neurochem. 28: 255–57.
- 40 Rydin, E., D. Schalling & M. Asberg 1982. Rorschach ratings in depressed and suicidal patients with low CSF 5-HIAA. Psych. Res. 7: 229–243.
- 41 Van Praag, H. M. Diagnosing depression. Looking backward into the future. Develop. in Psychiat.
- 42 Apter, A., H. M. van Praag. R. Plutchik, S. Sevy & S. L. Brown 1990. The relationships between a serotonergically linked series of psychopathological dimensions. Psychiatry Res. 32: 191–199.
- 43 Van Praag, H. M., R. Kahn, G. M. Asnis, C. Z. Lemus & S. L. Brown 1987c. Therapeutic indications for serotonin potentiating compounds. A hypothesis. Bio. Psych. 22: 205–212.
- 44 Van Praag, H. M., G. M. Asnis, R. S. Kahn, S. L. Brown, M. Korn, J. M. Harkavy Friedman & S. Wetzler 1990. Monoamines and abnormal behavior. A multiaminergic perspective. Br. J. Psych. In press.